Jeffrey C Kwong
Overview
Explore the profile of Jeffrey C Kwong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
313
Citations
5499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Swayze S, Bodner K, Calzavara A, Harrigan S, Siddiqi A, et al.
Am J Epidemiol
. 2025 Mar;
PMID: 40069958
Knowledge of patterns in COVID-19 deaths by area-level income over time and the mediating role of vaccination in inequality patterns remains limited. We used data from a population-based retrospective cohort...
2.
Chen H, Quick M, Kaufman J, Chen C, Kwong J, van Donkelaar A, et al.
Lancet Planet Health
. 2025 Feb;
9(2):e92-e102.
PMID: 39986327
Background: The impact of past air quality improvements on health and equity at low pollution levels near the revised WHO air quality guidelines remains largely unknown. Less is known about...
3.
Saeed Y, Mitsakakis N, Feld J, Krahn M, Kwong J, Wong W
Med Decis Making
. 2025 Feb;
:272989X251319342.
PMID: 39985398
Background: Hepatitis C virus (HCV) infection is associated with reduced quality of life and health utility. It is unclear whether this is primarily due to HCV infection itself or commonly...
4.
Ji C, Senthinathan A, Apajee J, Dubey V, Forte M, Kwong J, et al.
Vaccine
. 2025 Jan;
49:126811.
PMID: 39889534
Objectives: To assess immunization coverage for routine vaccinations in children (aged 4-7 years) and teenagers (aged 14-17 years) during the COVID-19 pandemic compared to the pre-pandemic period, in Ontario, Canada....
5.
Shields T, King K, Cripps S, Edwards S, Kwong J, Mecredy G, et al.
Vaccine
. 2025 Jan;
47:126665.
PMID: 39793536
From the beginning of the COVID-19 pandemic, the potential impact on Indigenous (First Nations, Métis and Inuit) communities in Canada was a major concern. Evidence from previous pandemics, particularly H1N1,...
6.
Aglipay M, Maguire J, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, et al.
Open Forum Infect Dis
. 2025 Jan;
12(1):ofae718.
PMID: 39758749
Background: Data on mRNA-1273 (Moderna) vaccine effectiveness (VE) in children aged 6 months to 5 years are limited. The objectives of this study were to assess mRNA-1273 vaccine effectiveness against...
7.
Grewal R, Nguyen L, Buchan S, Wilson S, Nasreen S, Austin P, et al.
Nat Commun
. 2024 Dec;
15(1):10709.
PMID: 39706844
No abstract available.
8.
Piche-Renaud P, Drover S, Austin P, Morris S, Buchan S, Nasreen S, et al.
Vaccine
. 2024 Dec;
44:126539.
PMID: 39617675
Background: Understanding how the efficacy of COVID-19 vaccines translates from clinical trials to real-world settings is critical to inform evolving vaccination policies. The objective of this study was to assess...
9.
Jorgensen S, Drover S, Fell D, Austin P, DSouza R, Guttmann A, et al.
BMJ Med
. 2024 Nov;
3(1):e000743.
PMID: 39574424
Objective: To examine the association between maternal mRNA covid-19 vaccination during the first trimester of pregnancy and the prevalence of major congenital anomalies in offspring. Design: Population based cohort study...
10.
Puyat J, Brode S, Shulha H, Romanowski K, Romanowski K, Menzies D, et al.
Clin Infect Dis
. 2024 Nov;
PMID: 39561254
Background: Tuberculosis (TB) incidence remains disproportionately high in people migrating to Canada and other low TB incidence countries, but systematic TB screening and prevention in migrants is often cost-prohibitive for...